Newman Michael James 13D and 13G filings for Indaptus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-10-26 5:17 pm Unchanged | 2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP | Newman Michael James | 1,388,356 16.900% | 0 (Unchanged) | Filing |
2021-08-13 3:50 pm Purchase | 2021-08-03 | 13D | Indaptus Therapeutics, Inc. INDP | Newman Michael James | 1,388,356 25.700% | 1,388,356![]() (New Position) | Filing |